Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia

Canadian Journal of Anaesthesia

Volumn 46, Issue 6, 1999, Pages 599-604

  Takahashi, Shinji ^a,b   Fujii, Yoshitaka ^a   Inomata, Shin Ichi ^a   Miyabe, Masayuki ^a   Toyooka, Hidenori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tsukuba Gakuen Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; HALOTHANE; LANDIOLOL;

ADRENALIN BLOOD LEVEL; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANESTHESIA; ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DOSE CALCULATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032775763     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013554     Document Type: Article

References (18)

1. Frishman WH. Clinical differences between beta-adrenergic blocking agents: implications for therapeutic substitution. Am Heart J 1987; 113: 1190-8.
2. Zaroslinski J, Borgman RJ, O'Donnell JP, et al. Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient. Life Sci 1982; 31: 899-907.
3. Gold MI, Sacks DJ, Grosnoff DB, Herrington C, Skillman CA. Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 1989; 68: 101-4.
4. Dyson A, Issac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg 1990; 71: 675-8.
5. Vucevic M, Purdy GM, Ellis FR. Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation. Br J Anaesth 1992; 68: 529-30.
6. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting ß- blocker, ONO-1101. Chem Pharm Bull Tokyo 1992; 40: 1462-9.
7. Muraki K, Nakagawa H, Nagano N, et al. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Phrmacol Exp Ther 1996; 278: 555-63.
8. Motomura S, Hagihara A, Narumi Y, Hashimoto K. Time course of a new ultrashort-acting ß- adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations. J Cardiovasc Pharmacol 1998; 31: 431-40.
9. 2 anesthesia in the dog. Anesth Analg 1979; 58: 401-4.
10. Kapur PA, Flacke WE. Epinephrine-induced arrhythmias and cardiovascular function after verapamil during halothane anesthesia in the dog. Anesthesiology 1981; 55: 218-25.
11. Hayashi Y, Sumikawa K, Yamatodani A, Tashiro C, Wada H, Yoshiya I. Myocardial sensitization by thiopental to arrhythmogenic action of epinephrine in dogs. Anesthesiology 1989; 71: 929-35.
12. Dimich I, Lingham R, Narang J, Sampson I, Shiang H. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs. Can J Anaesth 1992; 39: 83-6.
13. 2 adrenoceptor blockade on epinephrine-induced arrhythmias in halothane anaesthetized dogs. Can J Anaesth 1992; 39: 873-6.
14. Maze M, Smith CM. Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology 1983; 59: 322-6.
15. Sumikawa K, Ishizaka N, Suzaki M. Arrhythmogenic plasma levels of epinephrine during halothane, enflurane, and pentobarbital anesthesia in the dog. Anesthesiology 1983; 58: 322-5.
16. Kamibayashi T, Hayashi Y, Mammoto T, Yamatodani A, Sumikawa K, Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 1995; 81: 992-9.
17. Schick LM, Chapin JC, Munson ES, Kushins LG. Pancronium, d-tubocurarine, and epinephrine-induced arrhythmias during halothane anesthesia in dogs. Anesthesiology 1980; 52: 207-9.
18. Miletich DJ, Albrecht RF, Seals C. Responses to fasting and lipid infusion of epinephrine-induced arrhythmias during halothane anesthesia. Anesthesiology 1978; 48: 245-9.